| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,124,000 | 1,694,000 | 1,610,000 | 1,594,000 | | Cost of Revenue | 277,000 | 296,000 | 300,000 | 346,000 | | | Gross Profit |
-
| 1,398,000 | 1,310,000 | 1,248,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 826,000 | 866,000 | 750,000 | 834,000 | | Non Recurring | 45,000 | (27,000) | 223,000 | 469,000 | | Others | 600,000 | 842,000 | 961,000 | 626,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (283,000) | (624,000) | (681,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (624,000) | (283,000) | (624,000) | (681,000) | | Interest Expense | 15,000 | 106,000 | 118,000 | 178,000 | | Income Before Tax | (639,000) | (389,000) | (742,000) | (859,000) | | Income Tax Expense | (266,000) | (178,000) | (244,000) | (335,000) | | Minority Interest | 5,000 | 7,000 |
-
|
-
| | | | Net Income From Continuing Ops | (380,000) | (204,000) | (498,000) | (524,000) | | | Non-recurring Events | | Discontinued Operations | (29,000) | (12,000) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (397,000) | (216,000) | (498,000) | (524,000) | | Preferred Stock And Other Adjustments |
-
| 38,000 | (38,000) | (42,000) | | | Net Income Applicable To Common Shares | ($650,000) | ($178,000) | ($536,000) | ($566,000) |
|
0.03% Nasdaq 0.00%
Income Statement
